152 related articles for article (PubMed ID: 32934021)
1. Breast Cancer Cell Detection and Characterization from Breast Milk-Derived Cells.
Bhat-Nakshatri P; Kumar B; Simpson E; Ludwig KK; Cox ML; Gao H; Liu Y; Nakshatri H
Cancer Res; 2020 Nov; 80(21):4828-4839. PubMed ID: 32934021
[TBL] [Abstract][Full Text] [Related]
2. Genetic profiling of putative breast cancer stem cells from malignant pleural effusions.
Tiran V; Stanzer S; Heitzer E; Meilinger M; Rossmann C; Lax S; Tsybrovskyy O; Dandachi N; Balic M
PLoS One; 2017; 12(4):e0175223. PubMed ID: 28423035
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterization of CD44
Da Cruz Paula A; Leitão C; Marques O; Rosa AM; Santos AH; Rêma A; de Fátima Faria M; Rocha A; Costa JL; Lima M; Lopes C
Virchows Arch; 2017 Mar; 470(3):311-322. PubMed ID: 28116522
[TBL] [Abstract][Full Text] [Related]
4. CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome.
Idowu MO; Kmieciak M; Dumur C; Burton RS; Grimes MM; Powers CN; Manjili MH
Hum Pathol; 2012 Mar; 43(3):364-73. PubMed ID: 21835433
[TBL] [Abstract][Full Text] [Related]
5. Features of CD44+/CD24-low phenotypic cell distribution in relation to predictive markers and molecular subtypes of invasive ductal carcinoma of the breast.
Gudadze M; Kankava Q; Mariamidze A; Burkadze G
Georgian Med News; 2014 Mar; (228):81-7. PubMed ID: 24743129
[TBL] [Abstract][Full Text] [Related]
6. Identification of a stemness-related gene panel associated with BET inhibition in triple negative breast cancer.
Serrano-Oviedo L; Nuncia-Cantarero M; Morcillo-Garcia S; Nieto-Jimenez C; Burgos M; Corrales-Sanchez V; Perez-Peña J; Győrffy B; Ocaña A; Galán-Moya EM
Cell Oncol (Dordr); 2020 Jun; 43(3):431-444. PubMed ID: 32166583
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer stem cells and intrinsic subtypes: controversies rage on.
Nakshatri H; Srour EF; Badve S
Curr Stem Cell Res Ther; 2009 Jan; 4(1):50-60. PubMed ID: 19149630
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype.
Ricardo S; Vieira AF; Gerhard R; Leitão D; Pinto R; Cameselle-Teijeiro JF; Milanezi F; Schmitt F; Paredes J
J Clin Pathol; 2011 Nov; 64(11):937-46. PubMed ID: 21680574
[TBL] [Abstract][Full Text] [Related]
9. The expression of stem cell protein Piwil2 and piR-932 in breast cancer.
Zhang H; Ren Y; Xu H; Pang D; Duan C; Liu C
Surg Oncol; 2013 Dec; 22(4):217-23. PubMed ID: 23992744
[TBL] [Abstract][Full Text] [Related]
10. Distribution of cancer stem cells in ductal invasive carcinoma of breast (review).
Gudadze M; Kankava K; Mariamidze A; Burkadze G
Georgian Med News; 2013 Sep; (222):44-50. PubMed ID: 24099814
[TBL] [Abstract][Full Text] [Related]
11. Characterizing the HER2/neu status and metastatic potential of breast cancer stem/progenitor cells.
Pommier SJ; Quan GG; Christante D; Muller P; Newell AE; Olson SB; Diggs B; Muldoon L; Neuwelt E; Pommier RF
Ann Surg Oncol; 2010 Feb; 17(2):613-23. PubMed ID: 19838757
[TBL] [Abstract][Full Text] [Related]
12. Cancer stem cells markers CD44, CD24 and ALDH1 in breast cancer special histological types.
de Beça FF; Caetano P; Gerhard R; Alvarenga CA; Gomes M; Paredes J; Schmitt F
J Clin Pathol; 2013 Mar; 66(3):187-91. PubMed ID: 23112116
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic correlation of cancer stem cell markers CD44, CD24, VEGF and HIF-1α in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.
Wang Z; Shi Q; Wang Z; Gu Y; Shen Y; Sun M; Deng M; Zhang H; Fang J; Zhang S; Xie F
Pathol Res Pract; 2011 Aug; 207(8):505-13. PubMed ID: 21802218
[TBL] [Abstract][Full Text] [Related]
14. p53 mutation in breast cancer. Correlation with cell kinetics and cell of origin.
Megha T; Ferrari F; Benvenuto A; Bellan C; Lalinga AV; Lazzi S; Bartolommei S; Cevenini G; Leoncini L; Tosi P
J Clin Pathol; 2002 Jun; 55(6):461-6. PubMed ID: 12037031
[TBL] [Abstract][Full Text] [Related]
15. СD44+/CD24- markers of cancer stem cells in patients with breast cancer of different molecular subtypes.
Chekhun SV; Zadvorny TV; Tymovska YO; Anikusko MF; Novak OE; Polishchuk LZ
Exp Oncol; 2015 Mar; 37(1):58-63. PubMed ID: 25804234
[TBL] [Abstract][Full Text] [Related]
16. A quantitative proteomics analysis of MCF7 breast cancer stem and progenitor cell populations.
Nie S; McDermott SP; Deol Y; Tan Z; Wicha MS; Lubman DM
Proteomics; 2015 Nov; 15(22):3772-83. PubMed ID: 26332018
[TBL] [Abstract][Full Text] [Related]
17. Molecular definition of breast tumor heterogeneity.
Shipitsin M; Campbell LL; Argani P; Weremowicz S; Bloushtain-Qimron N; Yao J; Nikolskaya T; Serebryiskaya T; Beroukhim R; Hu M; Halushka MK; Sukumar S; Parker LM; Anderson KS; Harris LN; Garber JE; Richardson AL; Schnitt SJ; Nikolsky Y; Gelman RS; Polyak K
Cancer Cell; 2007 Mar; 11(3):259-73. PubMed ID: 17349583
[TBL] [Abstract][Full Text] [Related]
18. Origins of the breast milk-derived cells; an endeavor to find the cell sources.
Sani M; Hosseini SM; Salmannejad M; Aleahmad F; Ebrahimi S; Jahanshahi S; Talaei-Khozani T
Cell Biol Int; 2015 May; 39(5):611-8. PubMed ID: 25572907
[TBL] [Abstract][Full Text] [Related]
19. Are CD44
Ryspayeva DE; Smolanka II; Dudnichenko АS; Lyashenko AA; Grinevich YA; Gurianov VG; Koshubarova MV; Seleznev AA
Exp Oncol; 2017 Sep; 39(3):224-228. PubMed ID: 28967636
[TBL] [Abstract][Full Text] [Related]
20. Dual TGFβ/BMP Pathway Inhibition Enables Expansion and Characterization of Multiple Epithelial Cell Types of the Normal and Cancerous Breast.
Prasad M; Kumar B; Bhat-Nakshatri P; Anjanappa M; Sandusky G; Miller KD; Storniolo AM; Nakshatri H
Mol Cancer Res; 2019 Jul; 17(7):1556-1570. PubMed ID: 30992305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]